Docetaxel plus prednisone improves survival in men with advanced prostate cancer: Abstracted from: Tannock IF, de Wit R, Berry WR, et al. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004;351:1502–12.

✍ Scribed by Mike Shelley; Malcolm D. Mason

• Book ID: 116394974
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 91 KB
• Volume: 31
• Category: Article
• ISSN: 0305-7372
• DOI: 10.1016/j.ctrv.2005.05.003